Parkinson's disease L-DOPA D1 and D2 dopamine receptors Pitx3 deficient aphakia mice Fast scan cyclic voltammetry Dopamine transporter (DAT) Aromatic-L-amino acid decarboxylase (AADC) Cylinder test Olfactory bulb transplants Tyrosine hydroxylase (TH)-immunoreactive (ir) neurons have been found in the striatum after dopamine depletion; however, little is known about the mechanism underlying their appearance or their functional significance. We previously showed an increase in striatal TH-ir neurons after L-DOPA treatment in mice with unilateral 6-OHDA lesions in the striatum. In the present study, we further examined the time-course and persistence of the effects of chronic L-DOPA treatment on the appearance and regulation of TH-ir neurons as well as their possible function. We found that the L-DOPA-induced increase in striatal TH-ir neurons is dose-dependent and persists for days after L-DOPA withdrawal, decreasing significantly 10 days after L-DOPA treatment ends. Using hemiparkinsonian D1 receptor knock-out (D1R −/− ) and D2 receptor knock-out (D2R −/− ) mice, we found that the D1R, but not the D2R, is required for the L-DOPA-induced appearance of TH-ir neurons in the dopamine-depleted striatum. Interestingly, our experiments in aphakia mice, which lack Pitx3 expression in the brain, indicate that the L-DOPA-dependent increase in the number of TH-ir neurons is independent of Pitx3, a transcription factor necessary for the development of mesencephalic dopaminergic neurons. To explore the possible function of L-DOPA-induced TH-ir neurons in the striatum, we examined dopamine overflow and forelimb use in L-DOPA-treated parkinsonian mice. These studies revealed a tight spatio-temporal correlation between the presence of striatal TH-ir neurons, the recovery of electrically stimulated dopamine overflow in the lesioned striatum, and the recovery of contralateral forelimb use with chronic L-DOPA treatment. Our results suggest that the presence of TH-ir neurons in the striatum may underlie the long-duration response to L-DOPA following withdrawal. Promotion of these neurons in the early stages of Parkinson's disease, when dopamine denervation is incomplete, may be beneficial for maintaining motor function.
Introduction
The central neuropathology of Parkinson's disease (PD) is the degeneration of dopaminergic neurons in the substantia nigra, leading to a dramatic decrease in dopaminergic innervation of the striatum. This loss of striatal dopamine causes the debilitating motor symptoms that characterize PD. Until recently, these nigral dopaminergic neurons were thought to be the sole source of striatal dopaminergic innervation. However, animal and human studies have demonstrated that dopaminergic neurons exist in the striatum itself (Betarbet et al., 1997; Busceti et al., 2008; Cossette et al., 2005; Huot and Parent, 2007) . The number of these neurons increases significantly in animal models of Parkinson's disease (Betarbet et al., 1997; Darmopil et al., 2008; Jollivet et al., 2004; Lopez-Real et al., 2003; Mura et al., 1995 Mura et al., , 2000 .
These dopaminergic neurons in the striatum have been identified primarily based on expression of tyrosine hydroxylase (TH). Convincing evidence with BrdU experiments demonstrates that the striatal TH-immunoreactive (ir) neurons that appear in rodents and monkeys following dopaminergic denervation result from a phenotypic shift in which pre-existent GABAergic neurons begin to express TH, rather than from the birth of new neurons (Darmopil et al., 2008; Tandé et al., 2006) . The existence of resident striatal TH neurons was further demonstrated using EGFP-TH BAC transgenic mice. These mice have multiple copies of a modified BAC containing the TH gene in which the TH mRNA coding sequence was replaced by sequences encoding the EGFP reporter gene (Ibáñez-Sandoval et al., 2010) . In these mice, EGFP-positive neurons were evident in the striatum under basal conditions; however, TH-ir was only observed after colchicine treatment. Similarly, a more recent study in transgenic mice expressing EGFP under the control of the TH promoter reported the existence 
